Mabion S.A.

zł 7.72As of Sun 8 Nov 2026, 12:00 UTC
WSE:MABHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR (20.41%)
Div yield —
ROE (107.92%)
Biotechnology
Beta (5Y) 0.39
PE TTM —
TSR TTM (7.10%)
Mkt cap zł 124.8M
ROIC (70.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 9.34
20.94%
1.45%
Hold 2|9|8|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.10
0.11
0.12
0.12
9.24%
3.33%
15.56%
6.93%
Revenuezł M
16.55
17.26
17.28
17.57
10.15%
13.79%
14.14%
11.71%
Peers (US$31.51M)
Cap (US$)
PE
28.93M
—
28.69M
—
24.17M
—
Capital
TTM
5Y
10Y
Leveragex
0.154
(0.108)
(0.085)
EBIT/Intx
2.191
0.104
0.090
Own earn%
17.59
(37.43)
(46.44)
Sh yield%
52.10
21.07
19.90
Owners
Insiders/Inst%
10.37
57.62
Short interest%
5.13
SBC / revenue%
2.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
13–19
$1 testx
1.6
Incr. ROIC%
29